Spyre Therapeutics
SYRE
HK$119.07
Share price
0.03%
Change (1 day)
-58.87%
Change (1 year)
Categories
Spyre Therapeutics (SYRE) - P/B ratio
P/B ratio as of April 2025 : 1.80
According to Spyre Therapeutics's latest financial reports the company has a price-to-book ratio of 0.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Spyre Therapeutics - P/B ratio (from 2016 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | 2.73 | -35.11% |
| 2023-12-31 | 4.21 | 665.75% |
| 2022-12-31 | 0.5501 | -80.3% |
| 2021-12-31 | 2.79 | 3.47% |
| 2020-12-31 | 2.70 | -27.02% |
| 2019-12-31 | 3.70 | 37.92% |
| 2018-12-31 | 2.68 | 49.9% |
| 2017-12-31 | 1.79 | 92.79% |
| 2016-12-31 | 0.9279 | |
| 2015-12-31 | N/A | |
| 2014-12-31 | N/A |